Noventra Pharma Retatrutide Research Compound peptide Pen 64mg
Weight Loss • Metabolic Optimization • Craving Control
Retatrutide is an investigational peptide representing a significant advancement in metabolic health. As a triple-receptor agonist, it activates three key hormone receptors: the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor. Developed to optimize metabolic regulation and weight management, Retatrutide has demonstrated the ability to improve glucose homeostasis. Clinical trials indicate that it delivers substantial reductions in body weight over time, alongside improved metabolic markers in overweight or obese individuals.
Key Benefits – Noventra Pharma Retatrutide 64mg Peptide Pen
- Triple receptor agonist activity targeting GLP-1, GIP, and glucagon receptors
- Commonly researched for advanced metabolic and weight management support
- May assist with appetite regulation and reduced food cravings
- Potential support for improved energy expenditure and metabolic function
- Long-acting peptide profile designed for extended activity
- Convenient peptide pen format for precision handling and administration protocols
- High-quality compounded formulation from Noventra Pharma
- Designed for consistency, stability, and ease of use.
Disclaimer
This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPRA) for human or animal use.
Not for human consumption or medical use. Products sold on this website are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, the customer confirms they are qualified to handle and use this product in accordance with applicable laws and regulations.
